Com7 Public Company Limited (SET: COM7) and Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) jointly announced on Wednesday that their Boards of Directors at the meetings have approved both companies’ entry into a preliminary memorandum of understanding for a joint investment in order to establish a new joint venture company to operate a drugstore.
Registered capital is THB200,000,000, divided to 2,000,000 ordinary shares with the par value of THB100.00 per share.
The joint venture company, which is slated to incorporate in 2022, will focus on large-scale standalone drug stores in shopping malls.
According to the new company’s shareholding structure, BDMS controls 60%, while COM7 owns 40%.
Expected benefits include the fact that BDMS is an expert in medical services and business support for medical services businesses, while COM7 is an expert in retail business management. This corporation will contribute to the growth and expansion of both companies’ income. Additionally, it broadens the product offering for COM7’s retail operation.
